VitVio has partnered with the University Clinical Centre in Gdańsk (UCK) to bring its Vetro surgical AI platform to Poland. Announced October 14, 2026, the agreement makes UCK the first Polish hospital to deploy the 3D operating room system. Deployment will begin in selected rooms before a planned departmental expansion.
Inside the Vetro System
Vetro uses multiple cameras and ambient sensors to collect spatial data continuously during surgery. VitVio's Spatial Context Engine turns that data into a live geometric model showing activity and the stage of each surgical case. The platform targets coordination throughout the perioperative environment rather than automating a single task.
VitVio says the system removes identifiable information as activity is processed. The company says Vetro does not create biometric face or voice templates and can recognize surgical activities without identifying individuals. The approach seeks useful operational insight while limiting collection of personally identifying information.
The platform's AI agents automatically record surgical stages, detect delays as they occur and help coordinate personnel between cases. VitVio also plans capabilities for tracking instrument use and preparing operative notes in real time, with the objective of reducing waste and paperwork. These tools are designed to reduce administrative demands and return time to surgical teams.
Implementation and Expected Benefits
UCK will first introduce Vetro in a limited group of operating rooms before considering expansion across its surgical department. Observations from these initial rooms will guide the hospital's next steps and wider implementation decisions. The partners did not disclose a detailed timetable or the number of rooms in the first phase.
The partners expect improved coordination to reduce delays, ease administrative workloads and increase operating room utilization. Greater workflow visibility could allow more procedures within existing schedules, potentially reducing overtime and waiting lists. Those outcomes remain projections, with no performance results from UCK's deployment yet reported.
Leadership Perspectives
Adam Sudoł, UCK's vice president of medical logistics, emphasized the importance of preserving time for patient care and training surgeons, anesthetists and nurses. He said the experience gained from the first rooms would inform broader surgical management. UCK also sees potential benefits for medical education.
UCK CEO Jakub Kraszewski described the initiative as part of modernizing medicine in Poland. He said AI should support clinicians in their daily work rather than replace their expertise. UCK expects AI to become increasingly important in organizing healthcare.
VitVio co-founder and chief operating officer Maks Kozarzewski highlighted how paperwork and delays affect patients and trainees. He said recovering that time could benefit clinicians, patients and the next generation of medical staff. Kozarzewski also noted the significance of launching in Poland, given the founding team's Polish roots.
International Expansion and Company Background
UCK joins VitVio's growing roster of hospital partners in the United States, United Kingdom and elsewhere in Europe. In July 2026, VitVio opened access to Vetro across those markets, Latin America and the Middle East. The Gdańsk agreement extends the company's international reach into another national healthcare system.
Affiliated with the Medical University of Gdańsk, UCK provides specialized services in surgery, oncology, cardiology and neurology. VitVio was founded in 2024 by Thomas Knox, Peter Rennert, Maks Kozarzewski and Aleks Pajewski and reports $10 million in total funding. That includes an October 2025 $8 million seed round led by Bek Ventures, with LDV Capital and Balnord participating.
The partnership introduces Vetro to Polish operating rooms and expands VitVio's international presence. UCK's phased rollout will test its usefulness in routine surgical operations and identify potential workflow improvements. Further expansion will depend on the operational experience and measurable outcomes of the initial deployment.